Why the study?
Does continuous ambulatory peritoneal dialysis (CAPD) improve symptoms and functional status in patients with end-stage congestive heart failure refractory to conventional medical treatment?
Does continuous ambulatory peritoneal dialysis (CAPD) improve symptoms and functional status in patients with end-stage congestive heart failure refractory to conventional medical treatment?
Continuous ambulatory peritoneal dialysis (CAPD) may effectively improve symptoms and functional status in patients with end-stage, refractory congestive heart failure, serving as a palliative measure or bridge to transplantation.
May support CAPD for refractory HF palliation; leaves open efficacy and safety in prospective trials.
Four patients suffering from end-stage congestive heart failure (CHF) refractory to conventional medical treatment were treated with continuous ambulatory peritoneal dialysis (CAPD) for one to 21 months. All four patients improved from class IV CHF to class II, as defined by the New York Heart Association, and experienced a definite improvement in their sense of well-being. Three patients, women between 42 and 59 years of age with contraindications for heart transplantation, were all professionally rehabilitated. One 21-year-old patient received CAPD until he underwent a successful orthotopic heart transplantation. We thus propose CAPD as an effective treatment for end-stage CHF refractory to conventional medical treatment.
No takes yet. Share an insight, caveat, or question.
Paul König (1987) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: